ArticleFrontiers in microbiology2025
The tongue coating microbiome is perturbed in atrial fibrillation and partly normalized after catheter ablation.
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Gut microbiome and atrial fibrillation: mechanistic insights metabolites and comorbidities. Systematic review.Gut microbes · 2025Pooled it
- Oral Microbiota and Cardiovascular Diseases: A Study Integrating Genome-Wide Association and 16S rRNA Sequence Analyses.International dental journal · 2026Article
- Comparable tongue coating microbiota profiles from a simplified single-swab versus different sampling approaches: A pilot study.Clinical oral investigations · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is accumulating evidence linking the microbiome and cardiovascular diseases. Nevertheless, no existing studies have been conducted on atrial fibrillation (AF) and the oral microbiome. Materials and methods: We collected and sequenced 245 AF tongue-coating samples and 26 AF samples after catheter ablation from Zhengzhou and Guangshan, China. We characterized tongue coating microbiome, constructed microbial classifiers in the discovery cohort, and verified their diagnostic potential in a cross-regional cohort. Results: Tongue coating microbial richness and diversity were significantly increased in the AF group compared to the control group, indicating increased bacterial colonization. The classifiers based on four optimal tongue coating microbial markers achieved good diagnostic efficiency in AF cohorts, with area under the curve (AUC) of 99.10 and 98.62% in the discovery and validation cohorts, respectively, and 97.97% in the cross-regional cohort. Paroxysmal AF and persistent AF shared similar taxonomic features, but some specific differential bacteria acted in the AF progression. Moreover, the outcomes revealed that catheter ablation contributed to rehabilitating oral bacterial disorders. Conclusion: This was the first cross-sectional and longitudinal research of oral microbiome in AF patients and the alternations after catheter ablation, which offers promising new perspectives for AF clinical diagnosis and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.